Depression Treatment: [Diagnosis and Treatment of Anxiety-Depressive Disorders in Patients With Myocardial Infarction.]

[Diagnosis and treatment of anxiety-depressive disorders in patients with myocardial infarction.]

Filed under: Depression Treatment

Zh Nevrol Psikhiatr Im S S Korsakova. 2012; 112(11 Vypusk 2 Depressija): 91-95
Semiglazova MV, Krasnov VN, Dovzhenko TV, Lebedev AV

The results of the study of psychopathological, somatic and functional characteristics of anxiety-depressive disorders in patients with acute myocardial infarction are presented. The authors confirmed the wide prevalence of these disorders in acute myocardial infarction and described the features of their diagnostics, dynamics and response to complex treatment. The impact of anxiety-depressive disorders on the clinical and functional state of the cardiovascular system and the dynamics of the patient’s status due the concomitant anxiety-depressive disorder are considered.
HubMed – depression

[Depressive disorders in patients in remission of epilepsy.]

Filed under: Depression Treatment

Zh Nevrol Psikhiatr Im S S Korsakova. 2012; 112(11 Vypusk 2 Depressija): 86-90
Rogacheva TA, Mel’nikova TS

Based on the complex study of 150 patients with different forms of epilepsy in the remission phase, we singled out a group of 68 (45.3%) patients with depressive disorders. Variants of depressive disorders and their EEG-characteristics were described. Depressive disorders were stratified by the causes, course and response to pharmacotherapy into following variants: depressive disorders caused by the epileptic process per se; organic depressive disorder and disorder of adaptation with depression and anxiety-depressive disorders. Functional neuroimaging methods suggest the involvement of both the limbic system and cortical structures, with the elevated activity of the left hemisphere, in the development of depression.
HubMed – depression

[Treatment side effects and compliance in patients with depression.]

Filed under: Depression Treatment

Zh Nevrol Psikhiatr Im S S Korsakova. 2012; 112(11 Vypusk 2 Depressija): 77-85
Petrova NN, Kucher EO

The impact of treatment side-effects on the compliance was studied in 85 depressive patients with different mental disorders – recurrent depressive disorder, postschizophrenic depression and organic affective disorder. The comparison of objective and subjective evaluations of compliance and a comparative analysis of the level of compliance, with its dependence on the treatment specifics, in different diseases were done. A significant role of efficacy and treatment side-effects was identified. The levels of “mental” and “autonomous” side-effects were highest in the treatment of depression: patients with postschizophrenic depression had the highest risk in respect of maintenance treatment; patients with recurrent depressive disorder and organic (affective) disorder were more tolerant to the treatment side-effects and their treatment, including the maintenance therapy, was rather effective. The compliance of all patients with depression was negatively correlated with the severity of side-effects of pharmacotherapy. The greatest side-effects and the lowest level of compliance were observed in the complex treatment with antidepressants and atypical neuroleptics. The effect of side-effects on the compliance was dependent on their severity and subjective tolerability and, to a lesser extent, on the amount of drugs.
HubMed – depression

Treatment Of Depression In Managed Care (Mental Health Practice Under...

$3.95 End Date: Wednesday Nov-16-2016 18:48:18 PST Buy It Now for only: $3.95 Buy It Now | Add to watch list

$12.80 End Date: Saturday Oct-22-2016 15:51:18 PDT Buy It Now for only: $12.80 Buy It Now | Add to watch list

$27.89 End Date: Wednesday Nov-16-2016 13:50:39 PST Buy It Now for only: $27.89 Buy It Now | Add to watch list

More Depression Treatment Information…